exv10w63



 





EXHIBIT 10.63




IDM PHARMA, INC.

EMPLOYMENT AGREEMENT



This Employment Agreement (this “Agreement”) is made and entered into effective as of
May 25, 2007 by and among IDM Pharma Inc., a Delaware corporation (the “Company”) and
Timothy P. Walbert (the “Executive”). The Company and the Executive are hereinafter collectively
referred to as the “Parties”, and individually referred to as a “Party”.




Recitals




     A. The Company desires assurance of the association and services of the Executive in order to
retain the Executive’s experience, skills, abilities, background and knowledge, and is willing to
engage the Executive’s services on the terms and conditions set forth in this Agreement.



     B. The Executive desires to be in the employ of the Company, and is willing to accept such
employment on the terms and conditions set forth in this Agreement.



Agreement




     In consideration of the foregoing Recitals and the mutual promises and covenants herein
contained, and for other good and valuable consideration, the Parties, intending to be legally
bound, agree as follows:



     1. Employment.



          1.1 Term. The Company hereby employs the Executive, and the Executive hereby accepts
employment by the Company, upon the terms and conditions set forth in this Agreement. The
employment under this Agreement shall begin on the Effective Date and shall continue until it is
terminated pursuant to Section 4 herein (the “Term”).




          1.2 Title. The Executive shall have the title of President and Chief Executive Officer
(“CEO”) of the Company and shall serve in such other capacity or capacities commensurate with his
position as the Board of Directors of the Company (the “Board”) may from time to time prescribe.




          1.3 Duties. The Executive shall do and perform all services, acts or things necessary or
advisable to manage and conduct the business of the Company and shall have the authority and
responsibilities which are normally associated with the position of CEO. The Executive shall
report to the Board.




          1.4 Policies and Practices. The employment relationship between the Parties shall be governed
by this Agreement and the policies and practices established by the Company and the Board. The
Executive will acknowledge in writing that he has read the Company’s




1.









 




Employee Handbook that will govern the terms and conditions of his employment with the
Company, along with this Agreement. In the event that the terms of this Agreement differ from or
are in conflict with the Company’s policies or practices or the Company’s Employee Handbook, this
Agreement shall control.




          1.5 Location. Unless the Parties otherwise agree in writing, during the Term, the Executive
shall perform the services Executive is required to perform pursuant to this Agreement at the
Company’s offices, located in Irvine, California; provided, however, that the Company may from time
to time require the Executive to travel temporarily to other locations in connection with the
Company’s business.




     2. Loyal and Conscientious Performance; Noncompetition.



          2.1 Loyalty. During the Executive’s employment by the Company, the Executive shall devote the
Executive’s full business energies, interest, abilities and productive time to the proper and
efficient performance of Executive’s duties under this Agreement.




          2.2 Covenant not to Compete. During the Term of this Agreement, and during any period in
which the Executive receives severance benefits from the Company, the Executive shall not engage in
competition with the Company and/or any of its controlled Affiliates (as defined below), either
directly or indirectly, in any manner or capacity, as adviser, principal, agent, affiliate,
promoter, partner, officer, director, employee, stockholder, owner, co-owner, consultant, or member
of any association or otherwise, in any phase of the business of developing, manufacturing and
marketing of products or services that are in the same field of use or which otherwise compete with
the products or services of the Company, except with the prior written consent of the Company’s
Board. For purposes of this Agreement, “Affiliate,” means, with respect to any specific entity,
any other entity that, directly or indirectly, through one or more intermediaries, controls, is
controlled by or is under common control with such specified entity. Ownership by the Executive,
in professionally managed funds over which the Executive does not have control or discretion in
investment decisions, or as a passive investment, of less than two percent (2%) of the outstanding
shares of capital stock of any corporation with one or more classes of its capital stock listed on
a national securities exchange or publicly traded on the Nasdaq Stock Market or in the
over-the-counter market shall not constitute a breach of this Section 2.2.




          2.3 Agreement not to Participate in Company’s Competitors. During the Term, the Executive
agrees not to acquire, assume or participate in, directly or indirectly, any position, investment
or interest known by Executive to be adverse or antagonistic to the Company, its business or
prospects, financial or otherwise or in any company, person or entity that is, directly or
indirectly, in competition with the business of the Company or any of its Affiliates. Ownership by
the Executive, in professionally managed funds over which the Executive does not have control or
discretion in investment decisions, or as a passive investment, of less than two percent (2%) of
the outstanding shares of capital stock of any corporation with one or more classes of its capital
stock listed on a national securities exchange or publicly traded on the Nasdaq Stock Market or in
the over-the-counter market shall not constitute a breach of this Section 2.3.




2.









 





     3. Compensation of the Executive.



          3.1 Base Salary. The Company shall pay the Executive a base salary at the initial annualized
rate of three hundred ninety thousand dollars ($390,000) per year (“Base Salary”). Such Base
Salary shall be paid in accordance with the Company’s standard payroll practice. Such base salary
shall be prorated for any partial year of employment on the basis of a 365-day fiscal year.
Executive’s Base Salary will be reviewed annually.




          3.2 Discretionary Bonus. Provided the Executive meets the conditions stated in this Section
3.2, the Executive shall be eligible for an annual discretionary bonus (“Bonus”) with a target
amount of fifty percent (50%) of his annual salary, based on the Board’s determination in good
faith, in its sole discretion, of whether the Executive has met such performance milestones as are
established for the Executive by the Board in good faith in consultation with the Executive
(“Performance Milestones”). The Performance Milestones will be based on certain factors including,
but not limited to, the Executive’s performance and the Company’s financial performance. The
Executive’s bonus for 2007, if any, will be prorated based upon the fraction of the year that he is
employed by the Company where the numerator will equal the number of days employed in 2007 and the
denominator will equal three hundred sixty-five (365). The Board will have the sole discretion to
award any Bonus, to determine the amount of any such Bonus, and to determine the timing of the
payment of any Bonus, but shall act in good faith. The Executive must be employed on the date the
Bonus is awarded to be eligible for the Bonus, subject to the termination provisions thereof.




          3.3 Stock Options. Subject to the approval by the Company’s stockholders at the 2007 annual
stockholders’ meeting of an amendment to the Company’s 2000 Stock Plan, as amended (the “Plan”) to
increase the number of shares available for issuance under the Plan (the “Shareholder Approval
Requirement”), pursuant to the terms of the Plan, the Executive shall be granted, within 10 days of
commencing employment, an option to purchase two hundred thousand (200,000) shares of the Company’s
common stock (the “Option”). The exercise price of the Option will be set at the closing price of
the Company’s common stock as quoted on the Nasdaq Global Market on the date of the grant. The
Option will vest daily in equal installments over a period of four (4) years from the effective
date of this Agreement for so long as the Executive provides Continuous Service (as defined in the
Plan) to the Company.




          3.4 Deferred Issuance Restricted Stock Award. Subject to the Shareholder Approval
Requirement, pursuant to the terms of the Plan, the Executive will be granted, within 10 days of
commencing employment, a deferred issuance stock award covering eighty thousand (80,000) shares of
the Company’s common stock (the “Stock Award”). Forty thousand (40,000) shares of the Stock Award
shall vest on the first anniversary of the effective date of this Agreement and the remaining forty
thousand (40,000) shares of the Stock Award shall vest on the second anniversary of the effective
date of this Agreement, provided in both instances that the Executive shall have provided
Continuous Service (as defined in the Plan) to the Company through the vesting date(s). The Stock
Award shares shall issue upon the earlier of i) the fifth anniversary of the grant date; or ii) the
date upon which the Executive’s employment by the Company terminates, subject to, in the case of
either termination by the Company of the Executive’s employment without “Cause” (as defined below)
or termination by the Executive of




3.









 




the Executive’s employment for “Good Reason” (as defined below), the Executive’s delivery of a
fully effective waiver and release as provided by Section 4.4.3 of this Agreement in exchange for
any acceleration of shares provided by Section 4.4.3(iii) or (iv).




          3.5 Re-location Expenses. The Executive shall be reimbursed for reasonable expenses
associated with moving his place of residence from the Chicago, Illinois area to Irvine, California
to perform services for the Company, up to a maximum of twenty-five thousand dollars ($25,000).
Additionally, upon appropriate proof and verification of such expenses, and provided that the
Executive is employed by the Company on the date upon which such expenses are incurred, the Company
shall reimburse the Executive for the cost of renting a suitable residence in the Orange County
area for a period of up to six (6) months immediately following the Executive’s assumption of
duties under this Agreement, up to a maximum of four thousand five hundred dollars ($4,500) per
month. Such reimbursements will be paid no later than the calendar year following the year in
which the applicable expenses being reimbursed were incurred.




          3.6 Legal Review. Upon the Executive’s submission of appropriate itemized proof and
verification of reasonable and customary legal fees incurred by the Executive in obtaining legal
advice associated with review of this Agreement, the Company shall pay for such legal fees up to a
maximum of five thousand dollars ($5,000) subject to receipt of appropriate proof and verification
of such legal fees.




          3.7 Changes to Compensation. The Executive’s compensation may be changed from time to time by
mutual agreement of the Executive and the Company.




          3.8 Employment Taxes. All of the Executive’s compensation shall be subject to customary
withholding taxes and any other employment taxes as are commonly required to be collected or
withheld by the Company.




          3.9 Benefits. The Executive shall, in accordance with Company policy and the terms of the
applicable plan documents, be eligible to participate in benefits under any executive benefit plan
or arrangement which may be in effect from time to time and made available to the Company’s
executive or key management employees, provided however, that the Executive shall be entitled to at
least four (4) weeks of paid vacation annually.




     4. Termination.



          4.1 Termination By the Company. The Executive’s employment with the Company may be terminated
under the following conditions:




                    4.1.1 Termination for Death or Disability. The Executive’s employment with the Company shall
terminate effective upon the date of the Executive’s death or “Complete Disability” (as defined in
Section 4.4.1), provided, however, that this Section 4.1.1 shall in no way limit the Company’s
obligations to provide such reasonable accommodations to Executive as may be required by law.



4.









 





                    4.1.2 Termination by the Company For Cause. The Company may terminate the Executive’s
employment under this Agreement for “Cause” (as defined in Section 4.5.3) by delivery of written
notice to the Executive specifying the Cause or Causes relied upon for such termination, provided
that such notice is delivered within two (2) months following the occurrence of any event or events
constituting “Cause”. Any notice of termination given pursuant to this Section 4.1.2 shall effect
termination as of the date of the notice or such date as specified in the notice. The Executive
shall have the right to appear before the full Board before any termination for Cause.



                    4.1.3 Termination by the Company Without Cause. The Company may terminate the Executive’s
employment under this Agreement at any time and for any reason, or no reason. Such termination
shall be effective on the date the Executive is so informed or as otherwise specified by the
Company.



          4.2 Termination By The Executive. The Executive may terminate his employment with the Company
at any time and for any reason or no reason, including, but not limited, under the following
conditions:




                    4.2.1 Good Reason. The Executive may terminate his employment under this Agreement for “Good
Reason” (as defined below in Section 4.5.2) by delivery of written notice to the Company specifying
the “Good Reason” relied upon by the Executive for such termination, provided that such notice is
delivered within two (2) months following the occurrence of any event or events constituting Good
Reason.



                    4.2.2 Without Good Reason. The Executive may terminate the Executive’s employment hereunder
for other than Good Reason upon thirty (30) days written notice to the Company.



          4.3 Termination by Mutual Agreement of the Parties. The Executive’s employment pursuant to
this Agreement may be terminated at any time upon a mutual agreement in writing of the Parties.
Any such termination of employment shall have the consequences specified in such agreement.




          4.4 Compensation Upon Termination.




                    4.4.1 Death or Complete Disability. If the Executive’s employment shall be terminated by
death or Complete Disability as provided in Section 4.1.1, the Company shall pay to the Executive,
and/or Executive’s heirs, all earned but unpaid Base Salary, any earned but unpaid discretionary
bonuses for any prior period at such time as bonuses would have been paid if the Executive remained
employed, all accrued but unpaid business expenses and all accrued but unused vacation time earned
through the date of termination at the rate in effect at the time of termination (“Accrued
Amounts”), less standard deductions and withholdings, and the Company shall thereafter have no
further obligations to the Executive and/or Executive’s heirs under this Agreement, except to the
extent that the Executive and/or Executive’s heirs is/are eligible for benefits pursuant to any
insurance policies maintained by the Company in connection with his death or Complete Disability,
and except as otherwise provided by law. The Executive shall also be eligible to receive a
pro-rated bonus for the year of termination, as



5.









 







determined by the Board or the Compensation Committee of the Board based on actual performance
and the period of the year he was employed (the “Pro-rata Bonus”), less standard deductions and
withholdings, to be paid as a lump sum promptly after the date of termination.



                    4.4.2 With Cause or Without Good Reason. If the Executive’s employment shall be terminated by
the Company for Cause, or if the Executive terminates employment hereunder without Good Reason, the
Company shall pay the Executive’s Base Salary, accrued but unpaid business expenses and accrued and
unused vacation benefits earned through the date of termination at the rate in effect at the time
of termination, less standard deductions and withholdings, and the Company shall thereafter have no
further obligations to the Executive under this Agreement, except as provided by law.



                    4.4.3 Without Cause or For Good Reason. If the Company terminates the Executive’s employment
without Cause or the Executive terminates his employment for Good Reason, the Company shall pay the
Accrued Amounts and Pro-rata Bonus subject to standard deductions and withholdings, to be paid as a
lump sum promptly after the date of termination. In addition, subject to the limitations stated in
Section 4.4.5 herein and upon the Executive’s furnishing to the Company an effective waiver and
release of claims (the form of which is attached hereto as Exhibit A), the Executive shall be
entitled to:



                    (i) the equivalent of the Executive’s annual Base Salary in effect at the time of termination
for a period of twelve (12) months (the “Severance Period”), less standard deductions and
withholdings, to be paid as a lump sum promptly after the date of termination.



                    (ii) in the event the Executive elects continued coverage under COBRA, the Company will
reimburse the Executive for the same portion of Executive’s COBRA health insurance premium as the
percentage of health insurance premiums that it paid during the Executive’s employment up until the
earlier of either (i) the last day of the Severance Period or, (ii) the date on which the Executive
begins full-time employment with another company or business entity which provides comparable
health insurance coverage to the Executive.



                    4.4.4 Equity Award Acceleration.



                    (i) Not in connection with a Change in Control. In the event that the Executive’s employment
is terminated without Cause or for Good Reason before the first anniversary of the effective date
of this Agreement, and Section 4.4.4 (ii) below does not apply, the vesting of the Stock Award
shall be accelerated such that forty thousand (40,000) of the Stock Award shares shall be fully
vested and the vesting of the Option shall be accelerated such that twenty-five percent (25%) of
the Option shares shall be deemed vested and immediately exercisable. In the event that the
Executive’s employment is terminated without Cause or for Good Reason on or after the first
anniversary of the effective date of this Agreement, and Section 4.4.4(ii) below does not apply,
the vesting of the Stock Award shall be accelerated such that one hundred percent (100%) of the
Stock Award shares shall be fully vested.



6.









 





                    (ii) In connection with a Change in Control. In the event that the Executive’s employment is
terminated without Cause or for Good Reason within the ninety (90) days immediately preceding or
the twelve (12) months immediately following a Change in Control (as defined below) of the Company,
the vesting of the Option and the Stock Award shall be fully accelerated such that on the effective
date of such termination one hundred percent (100%) of the Option and Stock Award shares shall be
fully vested and immediately exercisable.



                    (iii) Release and waiver. Any acceleration pursuant to this Section 4.4.4 shall be
conditioned upon and subject to the Executive’s delivery to the Company of a fully effective
release as specified by Section 4.4.3 hereof and such acceleration shall be in addition to the
benefits provided by Section 4.4.3 hereof.



                    4.4.5 Conditions. Notwithstanding any provisions in this Agreement to the contrary, the
Company’s obligations and the Executive’s rights pursuant to Section 4.4.3 and 4.4.4 shall cease
and be rendered a nullity immediately should the Executive violate any provision of Section 2.2
herein, or should the Executive violate the terms and conditions of the Executive’s Proprietary
Information and Inventions Agreement.



          4.5 Definitions. For purposes of this Agreement, the following terms shall have the following
meanings:




                    4.5.1 Complete Disability. “Complete Disability” shall mean the inability of the Executive to
perform the Executive’s duties under this Agreement, whether with or without reasonable
accommodation, because the Executive has become permanently disabled within the meaning of any
policy of disability income insurance covering employees of the Company then in force. In the
event the Company has no policy of disability income insurance covering employees of the Company in
force when the Executive becomes disabled, the term “Complete Disability” shall mean the inability
of the Executive to perform the Executive’s duties under this Agreement, whether with or without
reasonable accommodation, by reason of any incapacity, physical or mental, which the Board, based
upon medical advice or an opinion provided by a licensed physician acceptable to the Board,
determines to have incapacitated the Executive from satisfactorily performing all of the
Executive’s usual services for the Company, with or without reasonable accommodation, for a period
of at least one hundred eighty (180) days during any twelve (12) month period (whether or not
consecutive). Based upon such medical advice or opinion, the determination of the Board shall be
final and binding and the date such determination is made shall be the date of such Complete
Disability for purposes of this Agreement.



                    4.5.2 Good Reason. “Good Reason” for the Executive to terminate the Executive’s employment
hereunder shall mean the occurrence of any of the following events without the Executive’s consent:



                    (i) a material reduction in the Executive’s duties, authority, or responsibilities relative to
the duties, authority, or responsibilities in effect immediately prior to such reduction;



7.









 





                    (ii) the relocation of the Company’s executive offices or principal business location to a
point more than thirty (30) miles from Irvine, California;



                    (iii) the relocation of the Executive’s principal place of business to a point more than
thirty (30) miles from the Irvine, California; or



                    (iv) a material reduction by the Company of the Executive’s base salary as initially set forth
herein or as the same may be increased from time to time, provided that if such reduction occurs in
connection with a Company-wide decrease in Executive salaries and the percent decrease in the
Executive’s base salary does not exceed the percent decrease in base salary of any other executive
of the Company such reduction will not constitute Good Reason to terminate Executive’s employment
for purposes of this Agreement.


Provided however that, such termination by the Executive shall only be deemed for Good Reason
pursuant to the foregoing definition if (i) the Company is given written notice from the Executive
within sixty (60) days following the first occurrence of the condition that he consider to
constitute Good Reason describing the condition and the Company fails to remedy such condition
within thirty (30) days following such written notice, and (ii) the Executive terminates employment
within thirty (30) days following the end of the period within which the Company was entitled to
remedy the condition constituting Good Reason but failed to do so.




                    4.5.3 Cause. “Cause” for the Company to terminate Executive’s employment hereunder shall mean
the occurrence of any of the following events, as determined reasonably and in good faith by the
Board or a committee designated by the Board:



                    (i) the Executive’s willful and habitual failure to attend to his duties as assigned by the
Board of Directors or officers of the Company to whom he reports;



                    (ii) willful misconduct by the Executive related to the Company or his duties which materially
and adversely reflects upon his ability to perform his duties for the Company;



                    (iii) the Executive’s conviction of a felony involving moral turpitude that is likely to
inflict or has inflicted material injury on the business of the Company;



                    (iv) the Executive’s engaging or in any manner participating in any activity which violates
any provisions of Section 2 hereof or the Executive’s Proprietary Information and Inventions
Agreement with the Company; or



                    (v) the Executive’s commission of any fraud against the Company, its controlled Affiliates,
employees, agents or customers or use or intentional appropriation for his personal use or benefit
of any funds or properties of the Company not authorized by the Board to be so used or
appropriated.



                    4.5.4 Change in Control. For purposes of this Agreement, “Change in Control” means: (i) a
sale of all or substantially all of the assets of the Company; (ii) a merger or consolidation in
which the Company is not the surviving entity and in which the holders of the



8.









 







Company’s outstanding voting stock immediately prior to such transaction own, immediately
after such transaction, securities representing less than fifty percent (50%) of the voting power
of the entity surviving such transaction or, where the surviving entity is a wholly-owned
subsidiary of another entity, the surviving entity’s parent; (iii) a reverse merger in which the
Company is the surviving entity but the shares of Common Stock outstanding immediately preceding
the merger are converted by virtue of the merger into other property, whether in the form of
securities of the surviving entity’s parent, cash or otherwise, and in which the holders of the
Company’s outstanding voting stock immediately prior to such transaction own, immediately after
such transaction, securities representing less than fifty percent (50%) of the voting power of the
Company or, where the Company is a wholly-owned subsidiary of another entity, the Company’s parent;
or (iv) an acquisition by any person, entity or group within the meaning of Section 13(d) or 14(d)
of the Exchange Act, or any comparable successor provisions (excluding any employee benefit plan,
or related trust, sponsored or maintained by the Company or subsidiary of the Company or other
entity controlled by the Company) of the beneficial ownership (within the meaning of Rule 13d-3
promulgated under the Exchange Act, or comparable successor rule) of securities of the Company
representing at least seventy-five percent (75%) of the combined voting power entitled to vote in
the election of Directors; provided, however, that nothing in this paragraph shall apply to a sale
of assets, merger or other transaction effected exclusively for the purpose of changing the
domicile of the Company.



          4.6 Survival of Certain Sections. Sections 2.2, 4.4.5, 5, and 16 of this Agreement will
survive the termination of this Agreement.




          4.7 Parachute Payment. If any payment or benefit the Executive would receive pursuant to this
Agreement (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G
of the Internal Revenue Code (the “Code”), and (ii) but for this sentence, be subject to the excise
tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be reduced to
the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment
that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest
portion of the Payment, which such amount, after taking into account all applicable federal, state
and local employment taxes, income taxes, and the Excise Tax (all computed at the highest
applicable marginal rate), results in the Executive’s receipt, on an after-tax basis, of the
greater amount of the Payment notwithstanding that all or some portion of the Payment may be
subject to the Excise Tax. If a reduction in payments or benefits constituting “parachute
payments” is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the
following order unless the Executive elects in writing a different order (provided, however, that
such election shall be subject to Company approval if made on or after the effective date of the
event that triggers the Payment): reduction of cash payments; cancellation of accelerated vesting
of stock awards; reduction of employee benefits. In the event that acceleration of vesting of
stock award compensation is to be reduced, such acceleration of vesting shall be cancelled in the
reverse order of the date of grant of the Executive’s stock awards unless the Executive elects in
writing a different order for cancellation.




9.









 





     The accounting firm then engaged by the Company for general audit purposes shall perform the
foregoing calculations. The Company shall bear all expenses with respect to the determinations by
such accounting firm required to be made hereunder.



     The accounting firm engaged to make the determinations hereunder shall provide its
calculations, together with detailed supporting documentation, to the Executive and the Company
within fifteen (15) calendar days after the date on which the Executive’s right to a Payment is
triggered (if requested at that time by the Executive or the Company) or such other time as
requested by the Executive or the Company. If the accounting firm determines that no Excise Tax is
payable with respect to a Payment, either before or after the application of the Reduced Amount, it
shall furnish the Executive and the Company with an opinion reasonably acceptable to the Executive
that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of
the accounting firm made hereunder shall be final, binding and conclusive upon the Executive and
the Company.



          4.8 Application of Internal Revenue Code Section 409A. Severance benefits paid pursuant to
Section 4.4.3(i) above are payable pursuant to the “short-term deferral” rule set forth in Section
1.409A-1(b)(4) of the Treasury Regulations. Notwithstanding the foregoing, if the Company
determines that any other payments hereunder fail to satisfy the distribution requirement of
Section 409A(a)(2)(A) of the Internal Revenue Code of 1986, as amended (the “Code”), the payment of
such benefit shall be delayed to the minimum extent necessary so that such payments are not subject
to the provisions of Section 409A(a)(1) of the Code.




          4.9 Board membership. In the event that the Executive is a member of the Board, on the
effective date of the termination of the Executive’s employment, the Executive shall immediately
resign from the Board. In the event that the Executive refuses to so resign, he shall be
automatically removed from the Board without the necessity of formal Board action and he shall
forfeit any and all right to the benefits provided by this Agreement.




          4.10 Indemnification Agreement. The Company and the Executive will enter into an
indemnification agreement in the Company’s standard form, a copy of which is attached hereto as
Exhibit B.




          5. Confidential And Proprietary Information.




          As a condition of employment the Executive agrees to execute and abide by the Company’s
standard form of proprietary information and inventions agreement.




          6. Assignment and Binding Effect.




          This Agreement shall be binding upon and inure to the benefit of the Executive and the
Executive’s heirs, executors, personal representatives, assigns, administrators and legal
representatives. Because of the unique and personal nature of the Executive’s duties under this
Agreement, neither this Agreement nor any rights or obligations under this Agreement shall be
assignable by the Executive. This Agreement shall be binding upon and inure to the benefit of the
Company and a successor, assigns and legal representatives, provided that the Agreement




10.









 




may only be assigned to an aquirer of all or substantially all of the Company’s assets. Any
such successor of the Company will be deemed substituted for the Company under the terms of this
Agreement for all purposes. For this purpose, “successor” means any person, firm, corporation or
other business entity which at any tie, whether by purchase, merger or otherwise, directly or
indirectly acquires all or substantially all of the assets or business of the Company.




          7. Notices.




          All notices or demands of any kind required or permitted to be given by the Company or the
Executive under this Agreement shall be given in writing and shall be personally delivered (and
receipted for) or faxed during normal business hours or mailed by certified mail, return receipt
requested, postage prepaid, addressed as follows:



If to the Company:



IDM Pharma Inc.

9 Parker

Suite 100

Irvine, California 92618

Attention: Chief Executive Officer



If to the Executive:



Timothy P. Walbert

c/o IDM Pharma Inc.

9 Parker

Suite 100

Irvine, California 92618



Any such written notice shall be deemed given on the earlier of the date on which such notice is
personally delivered or three (3) days after its deposit in the United States mail as specified
above. Either Party may change its address for notices by giving notice to the other Party in the
manner specified in this section.




          8. Choice of Law.




          This Agreement is made in the State of California. This Agreement shall be construed and
interpreted in accordance with the internal laws of the State of California.




          9. Integration.




          This Agreement, including Exhibit A, Exhibit B, the Stock Option Agreement and the Plan, as
well as the Employee Handbook contains the complete, final and exclusive agreement of the Parties
relating to the terms and conditions of the Executive’s employment and the termination of
Executive’s employment, and supersedes all prior and contemporaneous oral and written employment
agreements or arrangements between the Parties.




11.









 





          10. Amendment.




          This Agreement cannot be amended or modified except by a written agreement signed by the
Executive and the Company.




          11. Waiver.




          No term, covenant or condition of this Agreement or any breach thereof shall be deemed waived,
except with the written consent of the Party against whom the wavier is claimed, and any waiver or
any such term, covenant, condition or breach shall not be deemed to be a waiver of any preceding or
succeeding breach of the same or any other term, covenant, condition or breach.




          12. Severability.




          The finding by a court of competent jurisdiction of the unenforceability, invalidity or
illegality of any provision of this Agreement shall not render any other provision of this
Agreement unenforceable, invalid or illegal. Such court shall have the authority to modify or
replace the invalid or unenforceable term or provision with a valid and enforceable term or
provision, which most accurately represents the Parties’ intention with respect to the invalid or
unenforceable term, or provision.




          13. Interpretation; Construction.




          The headings set forth in this Agreement are for convenience of reference only and shall not
be used in interpreting this Agreement. This Agreement has been drafted by legal counsel
representing the Company, but the Executive has been encouraged to consult with, and has consulted
with, Executive’s own independent counsel and tax advisors with respect to the terms of this
Agreement. The Parties acknowledge that each Party and its counsel has reviewed and revised, or
had an opportunity to review and revise, this Agreement, and any rule of construction to the effect
that any ambiguities are to be resolved against the drafting party shall not be employed in the
interpretation of this Agreement.




          14. Representations and Warranties.




          The Executive represents and warrants that Executive is not restricted or prohibited,
contractually or otherwise, from entering into and performing each of the terms and covenants
contained in this Agreement, and that Executive’s execution and performance of this Agreement will
not violate or breach any other agreements between the Executive and any other person or entity.




          15. Counterparts.




          This Agreement may be executed in two counterparts, each of which shall be deemed an original,
all of which together shall contribute one and the same instrument.






12.









 








          16. Arbitration.




          To ensure the rapid and economical resolution of disputes that may arise in connection with
the Executive’s employment with the Company, the Executive and the Company agree that any and all
disputes, claims, or causes of action, in law or equity, arising from or relating to Executive’s
employment, or the termination of that employment, will be resolved, to the fullest extent
permitted by law, by final, binding and confidential arbitration pursuant to the Federal
Arbitration Act in Orange County, California conducted by the Judicial Arbitration and Mediation
Services/Endispute, Inc. (“JAMS”), or its successors, under the then current rules of JAMS for
employment disputes; provided that the arbitrator shall: (a) have the authority to compel adequate
discovery for the resolution of the dispute and to award such relief as would otherwise be
permitted by law; and (b) issue a written arbitration decision including the arbitrator’s essential
findings and conclusions and a statement of the award. Accordingly, the Executive and the Company
hereby waive any right to a jury trial. Both the Executive and the Company shall be entitled to
all rights and remedies that either the Executive or the Company would be entitled to pursue in a
court of law. The Company shall pay any JAMS filing fee and shall pay the arbitrator’s fee.
Nothing in this Agreement is intended to prevent either the Executive or the Company from obtaining
injunctive relief in court to prevent irreparable harm pending the conclusion of any such
arbitration. Notwithstanding the foregoing, the Executive and the Company each have the right to
resolve any issue or dispute involving confidential, proprietary or trade secret information, or
intellectual property rights, by Court action instead of arbitration.




          17. Trade Secrets Of Others.




          It is the understanding of both the Company and the Executive that the Executive shall not
divulge to the Company and/or its subsidiaries any confidential information or trade secrets
belonging to others, including the Executive’s former employers, nor shall the Company and/or its
Affiliates seek to elicit from the Executive any such information. Consistent with the foregoing,
the Executive shall not provide to the Company and/or its Affiliates, and the Company and/or its
Affiliates shall not request, any documents or copies of documents containing such information.




          18. Advertising Waiver.




          For so long as he remains employed, the Executive agrees to permit the Company, and persons or
other organizations authorized by the Company to use, publish and distribute advertising or sales
promotional literature concerning the products and/or services of the Company, or the machinery and
equipment used in the provision thereof, in which the Executive’s name and/or pictures of the
Executive taken in the course of the Executive’s provision of services to the Company appear. The
Executive hereby waives and releases any claim or right the Executive may otherwise have arising
out of such use, publication or distribution.




13.









 





          In Witness Whereof, the Parties have executed this Agreement as of the date first
above written.




IDM Pharma, Inc.




	 	 	 	 	 
	By:

	 	/s/ Sylvie Grégoire	 	 
	Its:

	 	 

Chairman of the Board
	 	 
	 
	 	 	 	 
	Dated:

	 	May 24, 2007	 	 
	 
	 	 	 	 
	Executive:	 	 
	 
	 	 	 	 
	/s/ Timothy P. Walbert	 	 
	 	 	 
	Timothy P. Walbert	 	 
	 
	 	 	 	 
	Dated:

	 	May 24, 2007	 	 






14.